- OUTLOOK
A simple test could extend cystic-fibrosis treatments to those left behind
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 583, S5 (2020)
doi: https://doi.org/10.1038/d41586-020-02107-9
This article is part of Nature Outlook: Cystic fibrosis, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Taylor-Cousar, J. L. et al. ERJ Open Res. 5, 00082-2019 (2019).
Fidler, M. C., Beusmans, J., Panorchan, P. & Van Goor, F. J. Cyst. Fibros. 16, 41–44 (2017).
Mall, M. A., Mayer-Hamblett, N. & Rowe, S. M. Am. J. Respir. Crit. Care Med. 201, 1193–1208 (2020).
Kim, J. et al. Sci. Rep. 8, 16233 (2018).